The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
Name
Xenpozyme
Active Substance
olipudaza alfa
Prescription
Medicinal product subject to medical prescription
Type of prescription
ograničeni recept
Distribution
Supply through pharmacies (community)
ATC Code
A16AB25
Summary of product characteristics (SmPC), labelling and package leaflet (PL)
